Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enovis Corporation (ENOV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
55.34-2.53 (-4.37%)
At close: 04:01PM EDT
55.34 +0.08 (+0.14%)
After hours: 04:01PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    Estimating The Fair Value Of Enovis Corporation (NYSE:ENOV)

    Today we will run through one way of estimating the intrinsic value of Enovis Corporation ( NYSE:ENOV ) by taking the...

  • GlobeNewswire

    Enovis Announces Second Quarter 2022 Results

    Sales of $395 million include 11% reported growth, 3% organic growth and 5% sales-per-day growthReported operating income of $6 million, while adjusted EBITDA increased 11% to $56 millionReported earnings per diluted share from continuing operations of $2.21; expanded adjusted earnings per share 44% to $0.59.Full year adjusted EBITDA and EPS outlooks updated to reflect currency impact and Q2 tax benefit Wilmington, DE, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innova

  • Business Wire

    Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery

    WILMINGTON, Del., July 19, 2022--Today, Enovis (NYSE: ENOV), an innovation-driven medical technology company, announced the commercial launch of ARVIS® (Augmented Reality Visualization and Information System) with over 200 cases successfully completed in the U.S. This FDA-cleared system is the only proprietary, real-time, hands-free augmented reality (AR) technology precisely engineered for orthopedic surgeons, so they can visualize precision guidance when performing hip and knee surgery with th

Advertisement
Advertisement